Sunitinib Malate Synergistically Potentiates Anti-Tumor Effect of Gemcitabine in Human Bladder Cancer Cells

PURPOSE: Sunitinib malate (Sutent; Pfizer, New York, NY, USA) is a highly selective multi-targeted agent and has been reported to have potent anti-tumor effects against various tumors, including renal cell carcinoma and gastrointestinal stromal tumors. In this study, we explored in vitro the anti-tu...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yoon, Cheol Yong, Lee, Jung Sun, Kim, Bo Sun, Jeong, Seong Jin, Hong, Sung Kyu, Byun, Seok Soo, Lee, Sang Eun
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Urological Association 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3037508/
https://ncbi.nlm.nih.gov/pubmed/21344032
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4111/kju.2011.52.1.55
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados